Rozov Yadin
SEC CIK 1921268 · EDGAR
BoughtSold
Most active insiders at DAVE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Khan Imran | Dir | — | $19.19M |
| 2 | Mitchell Andrea | Dir | — | $6.39M |
| 3 | Wilk Jason | CEO, Dir | — | $3.84M |
| 4 | Beilman Kyle | CFO, COO, Sec | — | $1.85M |
| 5 | Preston Dan | Dir | — | $139.6K |
| 6 | POPE MICHAEL W | Dir | — | $88.1K |
| 7 | Khajehnouri Nima | Dir | — | — |
| 8 | Rozov Yadin | Dir | — | — |
| 9 | Carroll Brendan | Dir | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-06-09 09:00 | 2026-06-05 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | G - Gift | $0.00 | -2,200 | 0 | -100% | $0 |
| 2026-06-04 18:00 | 2026-06-02 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | A - Grant | $0.00 | +637 | 75.8K | +0.8% | $0 | |
| 2026-02-06 | 2026-02-04 | CORZ | Core Scientific, Inc./tx | Rozov Yadin | Dir | A - Grant | $0.00 | +18.6K | 454.2K | +4% | $0 | |
| 2026-01-02 | 2025-12-30 | CORZ | Core Scientific, Inc./tx | Rozov Yadin | Dir | G - Gift | $0.00 | -40.1K | 435.6K | -8% | $0 | |
| MT | 2025-09-12 | 2025-09-12 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | S - Sale | $228.06 | -4,726 | 75.8K | -6% | -$1.08M |
| MT | 2025-09-05 | 2025-09-04 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | S - Sale | $199.54 | -14.7K | 84.5K | -15% | -$2.93M |
| I | 2025-06-11 | 2025-06-10 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | G - Gift | $0.00 | +2,200 | 2,200 | New | $0 |
| 2025-06-11 | 2025-06-10 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | G - Gift | $0.00 | -2,200 | 94.6K | -2% | $0 | |
| 2025-06-06 | 2025-06-02 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | A - Grant | $0.00 | +1,105 | 102.3K | +1% | $0 | |
| M | 2025-06-05 | 2025-06-04 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | S - Sale | $206.94 | -5,500 | 95.7K | -5% | -$1.14M |
| 2025-05-29 | 2025-05-28 | CORZ | Core Scientific, Inc./tx | Rozov Yadin | Dir | P - Purchase | $10.87 | +110.0K | 475.7K | +30% | +$1.20M | |
| 2025-01-28 | 2025-01-27 | CORZ | Core Scientific, Inc./tx | Rozov Yadin | Dir | A - Grant | $0.00 | +20.4K | 365.7K | +6% | $0 | |
| 2024-11-22 | 2024-11-22 | CORZ | Core Scientific, Inc./tx | Rozov Yadin | Dir | S - Sale | $18.11 | -105.0K | 345.2K | -23% | -$1.90M | |
| D | 2024-11-12 | 2024-11-11 | CORZ | Core Scientific, Inc./tx | Rozov Yadin | Dir | X - OptEx | $0.01 | +195.0K | 450.2K | +76% | +$1,950 |
| 2024-06-05 | 2024-06-03 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | A - Grant | $0.00 | +4,726 | 101.2K | +5% | $0 | |
| M | 2024-05-28 | 2024-05-27 | CORZ | Core Scientific, Inc./tx | Rozov Yadin | Dir | A - Grant | $0.00 | +175.2K | 255.2K | +219% | $0 |
| D | 2024-03-18 | 2024-03-15 | CORZ | Core Scientific, Inc./tx | Rozov Yadin | Dir | P - Purchase | $3.07 | +80.0K | 80.0K | New | +$245.6K |
| 2024-03-11 | 2024-03-07 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | P - Purchase | $37.31 | +800 | 96.5K | +0.8% | +$29.8K | |
| M | 2024-01-08 | 2024-01-04 | ORMP | ORAMED PHARMACEUTICALS INC. | Rozov Yadin | Dir | A - Grant | — | +38.8K | 146.5K | +36% | — |
| 2023-12-06 | 2023-12-04 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | P - Purchase | $6.40 | +12.9K | 95.7K | +16% | +$82.8K | |
| 2023-07-10 | 2023-07-06 | DAVE | Dave Inc./DE | Rozov Yadin | Dir | A - Grant | $0.00 | +30.2K | 82.7K | +58% | $0 | |
| 2023-04-20 | 2023-04-17 | ORMP | ORAMED PHARMACEUTICALS INC. | Rozov Yadin | Dir | A - Grant | — | +30.0K | 116.5K | +35% | — | |
| M | 2023-03-15 | 2023-03-13+ | ORMP | ORAMED PHARMACEUTICALS INC. | Rozov Yadin | Dir | P - Purchase | $2.02 | +70.0K | 36.5K | New | +$141.7K |
| 2022-08-01 | 2022-07-28 | ORMP | ORAMED PHARMACEUTICALS INC. | Rozov Yadin | Dir | A - Grant | — | +12.0K | 16.5K | +267% | — | |
| D | 2022-05-03 | 2022-05-02 | ORMP | ORAMED PHARMACEUTICALS INC. | Rozov Yadin | Dir | A - Grant | — | +4,500 | 4,500 | New | — |
Purchase Sale Sale after option exercise All abbreviations